logo
Select company
Select metric
14.91%Gross Profits to Assets
VS
Market
48
Sector
55
Industry
75
History
88
$ -1Close
$ -1 - $ -1 52-Week Range
Ticker Information

Ticker

SAGE

Company Name

SAGE THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SAGE THERAPEUTICS INC - Gross Profits to Assets Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SAGE - GPA Historical data
DateTotal AssetsGross ProfitGross Profits to Assets
6/30/2025$ 422.92M$ 63.04M14.91%
3/31/2025$ 469.67M$ 38.58M8.21%
12/31/2024$ 547.22M$ 31.8M5.81%
9/30/2024$ 622.43M$ 97.63M15.68%
6/30/2024$ 697.11M$ 92.84M13.32%
3/31/2024$ 767.6M$ 87.86M11.45%
12/31/2023$ 882.28M$ 84.3M9.55%
9/30/2023$ 949.66M$ 9.87M1.04%
6/30/2023$ 1.08B$ 9.61M0.89%
3/31/2023$ 1.22B$ 8.64M0.71%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SAGE THERAPEUTICS INC's latest trailing twelve months (TTM) GPA stands at 0.86%.
  • Over the past 5 years, SAGE THERAPEUTICS INC's average GPA has been 15.12%.
  • The median GPA for SAGE THERAPEUTICS INC during this period was 7.01%
  • SAGE THERAPEUTICS INC reached its highest GPA over the past 5 years at 57.77%.
  • The lowest GPA recorded by SAGE THERAPEUTICS INC in the same timeframe 0.32%

SAGE THERAPEUTICS INC's GPA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

GPA Benchmarks
CompanyGPA
KURA : KURA ONCOLOGY INC 12.2%TBPH : THERAVANCE BIOPHARMA INC 18.12%NKTR : NEKTAR THERAPEUTICS 30.13%ZVRA : ZEVRA THERAPEUTICS INC 17.41%LXRX : LEXICON PHARMACEUTICALS INC 25.69%ADCT : ADC THERAPEUTICS SA 22.43%YMAB : Y-MABS THERAPEUTICS INC 59.36%GOSS : GOSSAMER BIO INC 16.7%EYPT : EYEPOINT PHARMACEUTICALS INC 16.4%AUTL : AUTOLUS THERAPEUTICS PLC -3.31%

Definition of Gross Profits to Assets

[Calculation] Gross Profits to Assets (GPA) measures how effective a company leverages its assets to generate gross profits. It is calculated as gross profits [GP] divided by [Assets].
GP / Assets
(=) GPA
GPA for SAGE THERAPEUTICS INC is calculated as follows: GP [ $ 6.33M ] / Assets [ $ 738.63M ]
(=) GPA [ 0.86% ]

SAGE - Gross Profits to Assets, Last 5 years

0.32%

Minimum

Dec 31, 2021

57.77%

Maximum

Sep 30, 2021

15.12%

Average

7.01%

Median

GPA Benchmark Analysis

The chart above depicts the distribution of GPA for companies in the Total Stock Market. The average GPA of the companies is 20.16% with a standard deviation of 19.95%.
The following table provides additional summary stats:
GPA in the Market:
filtered constituents4.13K
min-50.32%
max83.98%
average20.16%
median15.35%
std19.95%